U.S. markets close in 46 minutes

Homology Medicines: 4Q Earnings Snapshot

BEDFORD, Mass. (AP) _ Homology Medicines Inc. (FIXX) on Thursday reported a loss of $24.2 million in its fourth quarter.

The Bedford, Massachusetts-based company said it had a loss of 55 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 72 cents per share.

The gene editing company posted revenue of $563,000 in the period.

For the year, the company reported that its loss widened to $103.9 million, or $2.47 per share. Revenue was reported as $1.7 million.

Homology Medicines shares have declined 32% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $14.06, a decline of 46% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX